Canadian Journal of Anesthesia, Vol 43, 379-383, Copyright © 1996 by Canadian Anesthesiologists' Society

ARTICLES

Intrathecal ketamine reduces morphine requirements in patients with terminal cancer pain

CY Yang, CS Wong, JY Chang and ST Ho
Department of Anesthesiology, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.

PURPOSE: Ketamine has been administered epidurally and intrathecally for operative and post-operative pain control. Animal studies showed potentiation of analgesia induced by ketamine and morphine. We hypothesized that intrathecal ketamine would potentiate the effects of intrathecal morphine in the treatment of cancer pain. METHODS: A double blind, cross over study was designed to evaluate the effect of ketamine on spinal morphine analgesia in terminal cancer pain patients. A two-phase protocol was used; phase M, intrathecal morphine alone twice daily; phase M + K, co-administration of ketamine (1.0 mg) with morphine intrathecally twice daily. The dose of morphine was titrated upwards until acceptable pain relief was achieved, defined by numeric rating scales (0-10) < or = 3, and the rescue dose of morphine was less than 5 mg after each intrathecal administration for two days. The dose of intrathecal morphine was defined as the effective dose. RESULTS: The effective dose of intrathecal morphine in phase M of 0.38 +/- 0.04 mg.day-1 was higher than that in phase M + K (0.17 +/- 0.02 mg.day-1) (P < 0.05). The average pain scales were 7.95 +/- 0.25 before intrathecal drug administration. Pain scales were decreased to 2.2 +/- 0.17 (P < 0.05) in phase M and 1.95 +/- 0.20 (P < 0.05) in phase M + K after the effective dose of morphine had been reached. No serious side effects were observed in this study. CONCLUSION: The present study demonstrates that ketamine enhances the analgesic effect of morphine, thus reducing the dose of intrathecal morphine.

This article has been cited by other articles:

				P. W. Keeley, E. T. Waterhouse, and S. I.R. Noble The evidence base of palliative medicine: is inpatient palliative medicine evidence-based? Palliative Medicine, October 1, 2007; 21(7): 623 - 627. [Abstract] [PDF]

				A. Bilir, S. Gulec, A. Erkan, and A. Ozcelik Epidural magnesium reduces postoperative analgesic requirement Br. J. Anaesth., April 1, 2007; 98(4): 519 - 523. [Abstract] [Full Text] [PDF]

				C. J. L. McCartney, A. Sinha, and J. Katz A Qualitative Systematic Review of the Role of N-Methyl-D-Aspartate Receptor Antagonists in Preventive Analgesia Anesth. Analg., May 1, 2004; 98(5): 1385 - 1400. [Abstract] [Full Text] [PDF]

				S. M. Walker, L. C. Goudas, M. J. Cousins, and D. B. Carr Combination Spinal Analgesic Chemotherapy: A Systematic Review Anesth. Analg., September 1, 2002; 95(3): 674 - 715. [Full Text] [PDF]

				G T Linklater, M E. Leng, E J. Tiernan, M A Lee, and W A Chambers Pain management services in palliative care: a national survey Palliative Medicine, July 1, 2002; 16(5): 435 - 439. [Abstract] [PDF]

				C.-S. Wong, Y.-C. Chang, C.-C. Yeh, G.-S. Huang, and C.-H. Cherng Loss of intrathecal morphine analgesia in terminal cancer patients is associated with high levels of excitatory amino acids in the CSF: [La perte d'analgesie morphinique intrathecale chez les patients atteints de cancer terminal est associee a des niveaux eleves d'acides amines excitateurs dans le LCR] Can J Anesth, June 1, 2002; 49(6): 561 - 565. [Abstract] [Full Text] [PDF]

				R. Nadeson, A. Tucker, E. Bajunaki, and C. S. Goodchild Potentiation by ketamine of fentanyl antinociception. I. An experimental study in rats showing that ketamine administered by non-spinal routes targets spinal cord antinociceptive systems Br. J. Anaesth., May 1, 2002; 88(5): 685 - 691. [Abstract] [Full Text] [PDF]

				S. Sator-Katzenschlager, E. Deusch, P. Maier, A. Spacek, and H. G. Kress The Long-Term Antinociceptive Effect of Intrathecal S(+)-Ketamine in a Patient with Established Morphine Tolerance Anesth. Analg., October 1, 2001; 93(4): 1032 - 1034. [Abstract] [Full Text] [PDF]

				P Good and B Stafford Inpatient palliative medicine is evidence based Palliative Medicine, September 1, 2001; 15(6): 493 - 498. [Abstract] [PDF]

				S. Himmelseher, D. Ziegler-Pithamitsis, H. Argiriadou, J. Martin, S. Jelen-Esselborn, and E. Kochs Small-Dose S(+)-Ketamine Reduces Postoperative Pain When Applied with Ropivacaine in Epidural Anesthesia for Total Knee Arthroplasty Anesth. Analg., May 1, 2001; 92(5): 1290 - 1295. [Abstract] [Full Text] [PDF]